/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $53M · -78.98% margin · -$57M FCF
The business is unprofitable at the operating level (-95.92% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 589.9% YoY with margins expanding 859.0pp.
Negative free cash flow of -$6M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$53M
▲ +589.9% YoY
Net Income (TTM)
-$31M
▲ +39.8% YoY
Op. Margin
-78.98%
▲ +859.0pp YoY
ROIC
-93.15%
▲ +29.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$57M
▲ +70.1% YoY
Op. Cash Flow (TTM)
-$56M
▲ +72.8% YoY
Net Debt
-$144M
Net Cash Position
Cash & Equiv.
$150M
Continue Research